TARGETED JAK2 MUTATION RESEARCH
Accutest LyoMorph-Q
JAK2 Mutation Detection Kit
Cost-effective and highly sensitive qPCR kit including lyophilized inhibitor-tolerant reagent mix with multiplex allele-specific primer-probe mix for the detection of the JAK2 V617F mutation in blood-derived genomic DNA.
*Nominal capacity before controls, repeats or invalid reactions. One primer/probe reaction is required per sample.
1 duplex qPCR reaction
reported 95% LoD
reported 95% LoD
reported study conditions
in the specificity study
POWERED BY SHARD DIAGNOSTICS™
One LyoMorph-Q platform. A growing oncology portfolio.
LyoMorph-Q uses standardized chemistry and cycling conditions across compatible targeted mutation panels, allowing multiple assays to run together on the same 96-well qPCR plate. The expanding portfolio supports focused solid- and blood-cancer research using cfDNA, FFPE-derived gDNA and gDNA.
Common workflow
Combine compatible mutation panels on one plate to improve throughput and reduce separate runs.
Growing assay menu
Build a scalable targeted-testing menu across established solid- and blood-cancer research panels.
Custom assay development
Discuss bespoke targets and panel combinations, including feasibility and low-minimum-order options.
Oncology technical support
Jant and shard-dx™ can support instrument compatibility, assay selection, evaluation planning and technical review.
Accutest LyoMorph-Q oncology assays are powered by SHARD DIAGNOSTICS™ (Nottingham, England). All products are for Research Use Only and are not for use in diagnostic procedures.
Highly sensitive JAK2 research in a familiar qPCR workflow
The kit combines mutation-specific amplification with reported low-copy detection of JAK2 V617F in blood-derived gDNA. No separate preamplification or post-PCR mutation-detection step is required.
The duplex reaction uses the universal LyoMorph-Q mastermix and shared cycling profile, supporting integration alongside compatible mutation panels on the same 96-well plate.
Use familiar qPCR workflows
Simple to adopt by using your existing cycler and expertise.
Support high-input research
The assay supports gDNA inputs from 1–750 ng, with enhanced detection enabled by high input.
Reduce cold-chain burden
Lyophilized chemistry supports ambient shipping. Follow the current documentation for storage after receipt and reconstitution.
Simplify analysis
Fixed thresholding supports simplified analysis through enhanced specificity.
Built for focused JAK2 V617F research
One mutation-specific duplex reaction detects JAK2 V617F (c.1849G>T) in FAM with an endogenous RNase P internal control in HEX.
High-input, low-copy JAK2 V617F detection
The reported 95% limit of detection was determined using 20 replicates on three instruments. The reported LoD is three mutant copies at 0.0012% VAF.
low-copy detection
JAK2 V617F
Specificity in the reported study conditions
No false-positive mutation amplification was reported in the supplied study using:
Results describe the reported study conditions and do not guarantee that false positives are impossible in every sample or laboratory.
| Protein change / control | Sequence change | Reaction | Fluorophore | Reported 95% LoD |
|---|---|---|---|---|
| V617F | c.1849G>T | 1 | FAM | 3 copies • 0.0012% VAF |
| RNase P internal control | Human DNA control | 1 | HEX | Not applicable |
From extracted DNA to an interpretable run
Extract and quantify
Prepare blood-derived gDNA and verify input concentration.
Reconstitute reagents
Rehydrate the lyophilized reagent mix with the specified buffer according to the current protocol.
Prepare the duplex reaction
Combine the JAK2 V617F/RNase P primer-probe mix with the sample and appropriate controls.
Run and interpret
Use the specified cycling and analysis settings. The universal 45-cycle program is approximately 75 minutes.
JAK2 kit FAQs
Which JAK2 variant is covered?
The kit detects JAK2 V617F, corresponding to sequence change c.1849G>T at codon 617.
What is the reported limit of detection?
The reported 95% LoD is three mutant copies at 0.0012% VAF for JAK2 V617F.
What is the role of RNase P?
RNase P is an endogenous human-DNA internal control detected in HEX in the duplex reaction. JAK2 V617F is detected in FAM.
Can compatible mutation panels run on the same plate?
Compatible LyoMorph-Q mutation panels use a universal mastermix and shared cycling profile, allowing multiple panels to run on the same 96-well qPCR plate. Instrument optics, fluorescence channels and each assay’s requirements must still be locally verified.
Which sample type is supported?
The JAK2 assay specifies blood-derived genomic DNA, with inputs from 1–750 ng.
Is the assay quantitative?
The kit is designed primarily for sensitive mutation screening, not absolute mutant copy-number quantification. Ct values should not be interpreted directly as mutant molecule counts.
How long is the PCR program?
The universal LyoMorph-Q cycling profile uses a 45-cycle, one-phase program completed in approximately 75 minutes on a standard 96-well qPCR cycler.
How is the kit shipped and stored?
The lyophilized kit supports ambient shipping. Follow the current product documentation for component-specific storage, reconstitution and stability requirements after receipt.
Is this JAK2 workflow a fit for your laboratory?
Tell us your sample type, target requirements and qPCR instrument. Jant’s molecular team can help review compatibility, documentation and evaluation needs.

